Therefore, we concluded that the higher efficiency of NPs with one versus two antibodies attached in accumulating in HER2+ tumours (Fig. 5a,b) is not caused simply by the reduced size of the NPs, but rather the number of surface ligands plays a crucial role. The gene discussed is ERBB2; the disease is neoplasm.